This literature review provides a comprehensive analysis of the clinical evidence supporting the use of PRP, G-CSF, GH, and stem cell therapy for the treatment of thin endometrium in women undergoing infertility treatment (Figure 1). The gene discussed is CSF3; the disease is Infertility.